Detalhe da pesquisa
1.
Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome.
J Oncol Pharm Pract
; 29(6): 1489-1493, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157792
2.
Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis.
Br J Haematol
; 198(5): 861-865, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499208
3.
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study.
Am J Hematol
; 97(9): 1189-1199, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731907
4.
A pharmacist's review of the treatment of systemic light chain amyloidosis.
J Oncol Pharm Pract
; 27(1): 187-198, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33028132
5.
Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature.
Am J Transplant
; 19(11): 3185-3190, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207062
6.
Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes.
Haematologica
; 108(6): 1680-1684, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546447
7.
Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes.
Am J Hematol
; 95(2): E45-E48, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736101
8.
Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition.
bioRxiv
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558967
9.
Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report.
Diagn Pathol
; 18(1): 1, 2023 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597112
10.
Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre.
Amyloid
; 30(3): 297-302, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36718932
11.
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis.
Blood Adv
; 7(20): 6080-6091, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581513
12.
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study.
Blood Cancer J
; 11(8): 139, 2021 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34349108
13.
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities.
Blood Cancer J
; 10(11): 118, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173025
14.
Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis.
Blood Adv
; 4(5): 880-884, 2020 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130406
15.
A new era of amyloidosis: the trends at a major US referral centre.
Amyloid
; 26(4): 192-196, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306033
16.
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans.
Blood Cancer J
; 12(7): 100, 2022 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35787622